Literature DB >> 10856685

Point dose variations with time during traditional brachytherapy for cervical carcinoma.

G C King1, W D Bloomer, S Kalnicki, C M Faul, W E Gooding, T F Stockstill, A Wu, R Buchsbaum, A S Chen, K Gerszten, A Kalend.   

Abstract

In traditional brachytherapy for carcinoma of the cervix, doses are often prescribed to specifically chosen points (A and B) and the normal tissue tolerance calculated at specific reference points in the bladder and rectum. These tolerance doses are often used to modify the brachytherapy treatment plan. It is inherently assumed that the position of the brachytherapy applicator does not change in relation to the relevant anatomical structures over the time-course of an implant. To assess the accuracy of this assumption, 2 sets of localization films were obtained for each implant in 28 patients, 1 prior to loading and another after the removal of the radioactive sources. Significant applicator movement and, consequently, significant dose variations were ob: served. Therefore, isolated one-time dose measurements to normal critical structures should not be used as the sole basis for making therapeutic decisions. The magnitude of dose variations and their clinical significant are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10856685     DOI: 10.1016/s0958-3947(00)00032-7

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  2 in total

1.  Tandem-ring dwell time ratio in Nigeria: dose comparisons of two loading patterns in standard high-dose-rate brachytherapy planning for cervical cancer.

Authors:  Obed Rachel Ibhade; Oyekunle Emmanuel Oyeyemi; Akinlade Bidemi Idayat; Ntekim Atara I
Journal:  J Contemp Brachytherapy       Date:  2015-04-01

2.  Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.

Authors:  Gurubasappa Patil; Kiran Kumar Br; Geeta Narayanan
Journal:  Cureus       Date:  2022-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.